home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> Genetic News | search  

Diabetic Drug Could Treat Common Liver Problem

  September, 11 2000 8:05
your information resource in human molecular genetics
As many as one quarter of adults in industrialized countries have excessive fat accumulation in the liver (fatty liver), a common cause of chronic liver disease which is frequently associated with obesity and diabetes.

Based on the understanding that fatty liver is associated with low levels of insulin and insulin-resistance, Anna Mae Diehl and coleagues at Johns Hopkins University tested the ability of the oral diabetes drug, metformin - which sensitizes the body to the effects of insulin - to improve the condition Nature Medicine (Vol 6, No. 9, September 2000).

The team found that metformin improved fatty liver disease in mice with a mutation in the obese (ob) gene, which develop obesity, diabetes and fatty liver. They propose that metformin achieves this by inhibiting liver production of tumor necrosis factor (TNF)a which promotes lipid accumulation.

Dr. Anna Mae Diehl
The Johns Hopkins University
GI Divivsion, 912 Ross Bldg.
720 Rutland Street
Baltimore, MD 21205
Phone #: 1 410 955 7316
Fax #: 410 955 9677
Email Address: amdiehl@welch.jhu.edu

(C) Nature Medicine press release.

Message posted by: Trevor M. D'Souza

print this article mail this article
Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2023 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.